Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 29, 2015 9:53 PM ET


Company Overview of Calyxt, Inc.

Company Overview

Cellectis Plant Sciences Inc operates as a subsidiary of Cellectis.

1000 Westgate Drive

Suite 101

St Paul, MN 55114

United States

Key Executives for Calyxt, Inc.

Chief Executive Officer
Chief Financial Officer
Age: 48
Vice President of Finance and Investor Relations
Director of Communications
Compensation as of Fiscal Year 2015.

Calyxt, Inc. Key Developments

Calyxt, Inc. Signs Exclusive License Agreement with Plant Bioscience Limited

Calyxt, Inc. announced that it has signed an exclusive license agreement with Plant Bioscience Limited for a bread wheat trait generated using gene editing. The trait provides endogenous resistance to powdery mildew of wheat, a fungus widely distributed throughout the world, responsible for major grain and yield losses.

S&W Seed Company and Calyxt, Inc. Announce Alfalfa Seed Collaboration

S&W Seed Company and Calyxt, Inc. announced that they have entered into a collaboration agreement to research, develop, produce and commercialize alfalfa seed products involving next generation gene editing technology on S&W's alfalfa seed genetics. Calyxt's technology allows for the custom gene-editing of plant species to create novel traits and increase value. In particular, Calyxt will be applying its patented nuclease technology to develop a series of alfalfa seed products based on editing of native genes to improve the agronomic and quality value of alfalfa for the food and agriculture industries. The approach is based on the same principle as classical cross-breeding of different plants, however the gene editing technology developed by Calyxt dramatically accelerates the development timeline. The targeted approach of gene editing is more predictable and reliable than traditional breeding and can also be much more cost effective. The companies will look to commercialize products through S&W and Calyxt's distribution channels with pre-defined financial terms.

Calyxt, Inc. Appoints Gregory R. Smith as Chief Financial Officer

Calyxt, Inc. announced the appointment of Gregory R. Smith as Chief Financial Officer. Previously Mr. Smith served in high-growth technology companies as CFO of Image Sensing Systems, Inc. and VP of Finance for Digital River, Inc.

Similar Private Companies By Industry

Company Name Region
Genovics United States
Ardea Biosciences, Inc. United States
Cypress Systems, Inc. United States
Cytolumina Technologies Corp., Inc. United States
iPierian, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Calyxt, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at